Vivoryon Therapeutics N.V. Presents Phase 2 Kidney Function and Biomarker Data at the American Society of Nephrology Kidney Week 2025 ...

T-cell lymphoma has remained an exceptionally challenging disease with limited therapeutic advances for far too long,” said Nicholas Siciliano, Ph.D., Chief Executive Officer of Vittoria ...

Also included is an improved Image Gallery experience and feature parity throughout application types BOZEMAN, Mont., Oct. 29, 2025 /PRNewswire/ -- Property information and mapping software company ...

Strong execution and continued progress across pipeline Positive Phase 2 barzolvolimab data in Chronic Spontaneous Urticaria (CSU) demonstrating ...

The group stage of the 2025 NBA Cup will pick up the pace Friday night with an 11-game slate. Here's where the Celtics stand ...

Toyota recalls more than 1 million vehicles worldwide due to rear camera error; MPV series receives 'huge' incentives at the ...

Full results from the Phase 2 REGEN-007 study of rilparencel were recently presented as a late-breaking clinical trial at the American Society of Nephrology (ASN) Kidney Week 2025More than half of the ...

Online romance has migrated from actual dating apps to… everywhere else. Here we break down the romantic potential of the ...

ASX device and diagnostic companies are intensifying their measures to expedite product rollouts and approvals in the US.

Gladstone Investment ( GAIN) Q2 2026 Earnings Call November 5, 2025 8:30 AM EST Greetings, and welcome to Gladstone Investment Corporation's Second Quarter Earnings Conference Call. [Operator ...

Three research scientist entrepreneurs with roots in university labs and life sciences startup companies have announced ...

Anika Therapeutics, Inc. (NASDAQ: ANIK) Q3 2025 Earnings Call Transcript November 5, 2025 Anika Therapeutics, Inc. misses on ...